We are live on ! Find out more
CCA

Conestoga Capital Advisors Portfolio holdings

AUM $5.01B
1-Year Est. Return 6.26%
This Fund
S&P 500
This Quarter Est. Return
+17.69%
1 Year Est. Return
+6.26%
3 Year Est. Return
+35.56%
5 Year Est. Return
+47.32%
10 Year Est. Return
+493.31%
AUM
$3.59B
AUM Growth
+$454M
Cap. Flow
-$12.8M
Cap. Flow %
-0.36%
Top 10 Hldgs %
30.05%
Holding
147
New
21
Increased
72
Reduced
15
Closed
3

Sector Composition

Rank Sector Weight
1 Technology 30.56%
2 Industrials 24.76%
3 Healthcare 18.78%
4 Consumer Discretionary 8.19%
5 Consumer Staples 6.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXPO icon
1
Exponent
EXPO
$3.05B
$134M 3.73%
2,319,167
+8,446
+0.4% +$456K
DSGX icon
2
Descartes Systems
DSGX
$6.35B
$125M 3.49%
3,449,473
+20,782
+0.6% +$672K
OMCL icon
3
Omnicell
OMCL
$2.09B
$125M 3.48%
1,546,168
+15,353
+1% +$1.15M
FOXF icon
4
Fox Factory Holding Corp
FOXF
$798M
$110M 3.07%
1,576,511
+15,880
+1% +$1.01M
MLAB icon
5
Mesa Laboratories
MLAB
$541M
$102M 2.83%
440,532
-45,724
-9% -$10.3M
PRO
6
DELISTED
PROS Holdings
PRO
$100M 2.79%
2,369,911
+15,525
+0.7% +$589K
SSD icon
7
Simpson Manufacturing
SSD
$7.78B
$97.6M 2.72%
1,646,072
+12,052
+0.7% +$712K
RGEN icon
8
Repligen
RGEN
$8.31B
$96.7M 2.69%
1,637,430
+21,393
+1% +$1.23M
EPAY
9
DELISTED
Bottomline Technologies Inc
EPAY
$95.8M 2.67%
1,913,436
+45,679
+2% +$2.21M
MGPI icon
10
MGP Ingredients
MGPI
$382M
$93.2M 2.59%
1,208,292
+27,992
+2% +$2.04M
MRCY icon
11
Mercury Systems
MRCY
$5.77B
$90.3M 2.51%
1,409,386
+7,899
+0.6% +$455K
NEOG icon
12
Neogen
NEOG
$2.24B
$88.7M 2.47%
3,092,116
+52,580
+2% +$1.59M
LOPE icon
13
Grand Canyon Education
LOPE
$3.72B
$88.2M 2.46%
770,484
+3,578
+0.5% +$369K
ROG icon
14
Rogers Corp
ROG
$2.36B
$87.4M 2.43%
550,387
+3,430
+0.6% +$463K
ACIW icon
15
ACI Worldwide
ACIW
$5.9B
$86.5M 2.41%
2,632,106
+21,601
+0.8% +$658K
CMD
16
DELISTED
Cantel Medical Corporation
CMD
$83.3M 2.32%
1,245,484
+13,175
+1% +$998K
BLKB icon
17
Blackbaud
BLKB
$1.49B
$80.6M 2.24%
1,011,365
+9,934
+1% +$729K
LGND icon
18
Ligand Pharmaceuticals
LGND
$6.08B
$78.1M 2.17%
995,473
+215,080
+28% +$16.3M
ESE icon
19
ESCO Technologies
ESE
$8.25B
$76.8M 2.14%
1,145,389
+8,941
+0.8% +$599K
BCPC
20
Balchem Corp
BCPC
$5.25B
$74.4M 2.07%
801,988
+6,104
+0.8% +$527K
AAON icon
21
Aaon
AAON
$9.13B
$73.6M 2.05%
2,391,717
-81,738
-3% -$2.15M
PLOW icon
22
Douglas Dynamics
PLOW
$1.03B
$73.1M 2.03%
1,920,188
+47,673
+3% +$1.78M
TREX icon
23
Trex
TREX
$4.69B
$72.6M 2.02%
2,359,358
+38,474
+2% +$1.34M
DORM icon
24
Dorman Products
DORM
$4.24B
$69.9M 1.95%
793,888
+6,145
+0.8% +$534K
HLIO icon
25
Helios Technologies
HLIO
$2.68B
$69.3M 1.93%
1,489,937
+10,532
+0.7% +$421K

Similar funds

Conestoga Capital Advisors's Q1 2019 Portfolio in Review

As of Q1 2019, Conestoga Capital Advisors held 147 positions worth $3.59B, up 14% from $3.14B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Conestoga Capital Advisors's Q1 2019 filing shows 21 new, 72 increased, 15 reduced and 3 closed positions. Its largest new stake was Axon Enterprise: 785,855 shares worth $42.8M. The largest sale was Stamps.com, Inc., an estimated $69.7M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Industrials and Healthcare.

  • Conestoga Capital Advisors's largest Q1 2019 buy was Axon Enterprise: 785,855 shares worth $42.8M.
  • Conestoga Capital Advisors added most to Ligand Pharmaceuticals in Q1 2019, an estimated $16.3M increase.
  • Conestoga Capital Advisors's biggest Q1 2019 reduction was Healthcare Services Group, cutting an estimated $11.8M.
  • Conestoga Capital Advisors fully exited Stamps.com, Inc. in Q1 2019, selling an estimated $69.7M.
  • Conestoga Capital Advisors's ten largest holdings make up 30% of its $3.59B portfolio in Q1 2019.
  • Conestoga Capital Advisors opened 21 new positions and closed 3 in Q1 2019.
  • Conestoga Capital Advisors's portfolio value rose 14% quarter-over-quarter to $3.59B.

Based on Conestoga Capital Advisors's 13F filing for Q1 2019, filed 18 Apr 2019.